Respiratory
Respiratory
Boehringer Ingelheim
has over 90 years
of heritage
in managing
respiratory diseases
Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life
New GOLD recommendations: ICS usage and eosinophil count as biomarker
Document ID: PC-TH-100385
01/03/2019
Author: Prof. Claus F. Vogelmeier
Related content
PC-TH-100292
Production date: Mar 2019
Production date: Mar 2019
